Address https://gelex.eu/eli/EU/decision/2007/682@2007-10-18/en

Contents

1. Preamble
2. 1. Article 1
   2. Article 2
   3. Article 3
   4. Article 4
   5. Article 5

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Decision 90/424/EEC of 26 June 1990 on expenditure in the veterinary field, and in particular Article 6(2) and Article 8(2) thereof,

Having regard to Council Directive 2001/89/EC of 23 October 2001 on Community measures for the control of classical swine fever, and in particular Article 18(2) thereof,

Whereas:

(1) Classical swine fever is a threat for domestic and feral pigs (wild boar) in the Community.

(2) Outbreaks of classical swine fever in domestic pig holdings can lead to serious consequences and economic losses in the Community, in particular if they occur in areas with a high density of pigs.

(3) The rules for applying emergency vaccination of domestic and feral pigs are laid down in Directive 2001/89/EC.

(4) The Community has purchased 1000000 doses of live attenuated classical swine fever vaccine and made arrangements for keeping it in stock and making it rapidly available in case of an emergency vaccination of domestic pigs.

(5) Those doses have been made available to Romania in July 2007. Accordingly, they need to be replaced for the purpose of maintaining the Community’s capability to respond quickly to the need to carry out emergency vaccination against classical swine fever.

(6) In addition, in the light of the overall disease situation in certain Member States the stock of live attenuated vaccine should be replaced quickly when depleted in order to maintain the Community’s capability to respond to an emergency.

(7) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

HAS ADOPTED THIS DECISION:

Article 1

1. The Community shall purchase as soon as possible 1000000 doses of live attenuated classical swine fever vaccine.

2. The Community shall make arrangements for the storage and distribution of the vaccine referred to in paragraph 1.

Article 2

If the stock of vaccine referred to in Article 1(1) becomes depleted, it may be replaced by 1000000 doses up to four times during a period of five years after the date of the first purchase.

Article 3

The maximum cost of the measures referred to in Articles 1 and 2 shall not exceed EUR 1500000.

Article 4

The measures provided for in Article 1(2) shall be carried out by the Commission in cooperation with the suppliers designated by call for tender.

Article 5

This Decision is addressed to the Member States.

Done at Brussels, 18 October 2007. For the Commission Markos Kyprianou Member of the Commission

Versions

1. 2007-10-18

Cited by

• Commission Delegated Regulation (EU) 2022/139 of 16 November 2021 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the management, storage and replacement of stocks of the Union antigen, vaccine and diagnostic reagent banks and the biosecurity, biosafety and bio-containment requirements for the operation of those banks (Text with EEA relevance) Regulation · Grade B

  Prior to the date of application of Regulation (EU) 2016/429 on 21 April 2021, the Commission already established and maintained the following Union banks: the foot-and-mouth disease antigen and vaccine bank in accordance with Council Decision 91/666/EEC and with Article 80(1) of Council Directive 2003/85/EC; the classical swine fever vaccine bank in accordance with Article 18(2) of Council Directive 2001/89/EC and with Commission Decision 2007/682/EC; and the lumpy skin disease vaccine bank, peste des petits ruminants vaccine bank and sheep pox and goat pox vaccine bank in accordance with Art

• Commission Delegated Regulation (EU) 2022/139 of 16 November 2021 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the management, storage and replacement of stocks of the Union antigen, vaccine and diagnostic reagent banks and the biosecurity, biosafety and bio-containment requirements for the operation of those banks (Text with EEA relevance) Regulation · Grade B

  vaccines against classical swine fever, established in accordance with Article 18(2) of Directive 2001/89/EC and with Decision 2007/682/EC;